N/A
N=36
Effectiveness of Taping on Anastomotic Regions in Patients With Breast Cancer-Related Lymphoedema
Breast Cancer Lymphedema · Compression Bandages · Manual Lymphatic Drainage
Bottom Line
View on ClinicalTrials.gov: NCT03765996 ↗Enrolled (actual)
36
Serious AEs
0.0%
Results posted
Apr 2020
Primary outcome: Primary: Change of the Limb Volume, (Last Value of the Follow-up - Baseline Value) — 160.01; 148.28 milliliter
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Decongestive Physiotherapy (Other); Decongestive Physiotherapy plus taping (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Dokuz Eylul University
- Primary completion
- Jan 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change of the Limb Volume, (Last Value of the Follow-up - Baseline Value) |
160.01; 148.28 | — |
Summary
One of the most common conservative treatments of lymphoedema is Complex Decongestive Physiotherapy (CDP). The bandage is one of the most important components of the treatment process. The multilayer short-stretch bandage is used to maintain volume reduction and prevent lymph backflow caused by compression. However, some patients refuse or postpone treatment or show a lower compliance with compression bandaging.Kinesio® Tex tape (KT) is a new technique for managing lymphoedema in the field of physical and alternative therapy, and it may affect decongestion of lymphatic fluid accumulated under the skin. Some studies which showed that KT was an effective for patients with BCRL, it was applied on both the affected arm and anastomosis. One of these studies also reported that a significant reduction in limb volume in patients who were applied of the tape only to the affected arm. This significant effect could also be seen by applying KT only to the anastomosis. In literature, however, there is no evidence to support this theory. So the aim of this study is to determine the effectiveness of KT which was applied to anastomotic regions along with CDP in the management of BCRL.
Eligibility Criteria
Inclusion Criteria
- Patients who had unilateral BCRL and women aged over 18 who were 'significant', 'marked', or 'severe' lymphoedema.
Exclusion Criteria
- Patients with paralysis on part of the affected arm,
- Patients who had undergone CDP more than once within six months,
- Patients who had an active infection,
- Patients who had a skin disease.
Data sourced from ClinicalTrials.gov (NCT03765996). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.